Zoetis | ZTS - Current Liabilities


Zoetis reported $2.05B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
AbbVie USD 42.1B 1.19B Mar/2026
Align Technology USD 1.91B 14.16M Mar/2026
Bayer EUR 33.46B 875M Mar/2026
Bristol-Myers Squibb USD 19.16B 4.26B Mar/2026
Charles River Laboratories USD 1.09B 26.61M Mar/2026
Coherus Biosciences USD 140.39M 231.91M Dec/2025
Dentsply International USD 1.21B 136M Mar/2026
Eli Lilly USD 36.63B 1.41B Mar/2026
Henry Schein USD 3.3B 69M Mar/2026
Idexx Laboratories USD 1.3B 151.04M Mar/2026
Illumina USD 1.57B 19M Mar/2026
IQVIA Holdings USD 8.33B 9M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Laboratory Of America USD 2.64B 182.5M Mar/2026
Merck USD 26.94B 1.38B Mar/2026
Neogen USD 150.6M 3.55M Dec/2025
Pacira USD 108.79M 11.8M Mar/2026
Perrigo USD 997.6M 15.3M Mar/2026
Pfizer USD 34.35B 2.64B Mar/2026
Phibro Animal Health USD 281.87M 500K Mar/2026
Quest Diagnostics USD 2.18B 101M Mar/2026
Sanofi EUR 30.01B 1.66B Mar/2026
Sanofi EUR 28.35B 9.32B Dec/2025
Zoetis USD 2.05B 182M Mar/2026